Pathophysiologic pathways and drug interventions in SCD. The pathologic RBCs containing HbS and microparticles derived from them give rise to a multiplicity of highly interactive pathways that contribute to hemolysis and organ damage. Various FDA-approved drugs as well as other classes of compounds may serve to reduce one or more of these processes and thus ameliorate the symptoms of the disease. O₂, oxygen.